Total cholesterol to HDL ratio = total cholesterol ÷ HDL cholesterol, both in the same units.
The ratio has no single official band, but the lipoprotein ratio review cited on this page sets risk levels for people without heart disease above 5.0 in men and above 4.5 in women. Its suggested targets are below 4.5 for men and below 4.0 for women, with lower targets for people who already have heart disease.
A result under the target does not mean heart risk is low, and a result above the risk level does not mean heart disease is present. The ratio is one piece of a risk picture that also includes age, blood pressure, smoking, diabetes and family history.
It also helps to look at the two inputs. The ATP III report treats total cholesterol below 200 mg/dL as desirable, 200 to 239 as borderline high and 240 or above as high. It treats HDL below 40 mg/dL as low and 60 or above as high. The same ratio can come from very different pairs of numbers, and those pairs are read differently.
Anything that raises total cholesterol or lowers HDL pushes the ratio up. Total cholesterol includes LDL and the cholesterol in triglyceride-rich particles, so higher triglycerides tend to lift the top of the ratio while also pulling HDL down. That double effect is part of why the ratio tracks heart risk.
The ATP III report notes that HDL tends to be lower with smoking, excess body weight, physical inactivity, high triglycerides and type 2 diabetes. It also lists medicines that can lower HDL, including anabolic steroids, progestins and beta blockers. Regular aerobic activity and weight loss tend to move HDL in the other direction.
Conditions such as an underactive thyroid, some kidney conditions and obstructive liver disease can raise total cholesterol. Lipid-lowering medicines lower the top number, and some also shift HDL. A ratio taken on treatment is therefore read in the context of that treatment.
Total cholesterol and HDL change little after an ordinary meal, so a nonfasting panel is usually fine for this ratio. A result that is much higher than earlier panels is still worth repeating under similar conditions, at a similar time of day and without a recent illness, before drawing conclusions.
Ratios move slowly with lifestyle change. Rechecking within days rarely tells you anything new, while a repeat panel after a few months of steady change gives a clearer read. When a clinician has started or changed lipid treatment, they set the recheck interval.
A ratio above the risk level for your sex, especially with other risk factors such as smoking, high blood pressure or diabetes, is worth discussing with a clinician rather than tracking on your own. A very low HDL on its own is also worth raising, because it can reflect other metabolic or medical conditions.
The ratio compresses two numbers into one, so it hides how you got there. A total cholesterol of 300 with an HDL of 75 and a total cholesterol of 160 with an HDL of 40 both give 4.0, yet a clinician would not read those panels the same way.
The risk levels in the review come from mostly middle-aged adults in large population studies. They were not built for children, pregnancy, or people with rare inherited lipid disorders, and they say nothing about very high HDL, which is not always protective.
The ratio also does not capture particle number, lipoprotein(a) or the size of LDL particles. Those can matter for some people and need separate tests. The ratio is a good summary, but not the whole story, and it is read together with the full panel.
Take a total cholesterol of 200 mg/dL and an HDL of 45 mg/dL from the same panel. The formula is total cholesterol divided by HDL, so 200 divided by 45 gives 4.444, which the calculator rounds to 4.4. In mmol/L the same blood gives the same ratio, because the units cancel out.
For a man without heart disease, 4.4 sits below the review's risk level of 5.0 and just under its target of 4.5. For a woman without heart disease, the same 4.4 is below the risk level of 4.5 but above the target of 4.0. The same number can sit in a different place depending on sex.
Now look at the inputs. A total cholesterol of 200 is right at the ATP III line between desirable and borderline high, and an HDL of 45 is above the low cut-off of 40 but well under the high mark of 60. A clinician would read the ratio together with LDL, triglycerides and the person's other risk factors before saying what it means.
If the same person's HDL rose to 55 with no change in total cholesterol, 200 divided by 55 gives 3.636, and the ratio would fall to 3.6. That shows how much the bottom number moves the result, and why a change in HDL alone can shift the ratio across a target.
A 1994 analysis by Kinosian and colleagues in three large US data sets found that the total cholesterol to HDL ratio and the LDL to HDL ratio predicted coronary heart disease better than single cholesterol levels. The lipoprotein ratio review on this page reached a similar conclusion.
The Quebec Cardiovascular Study compared the total to HDL ratio with the LDL to HDL ratio in men. Lemieux and colleagues found the total to HDL ratio was the more useful of the two, partly because it also reflects the cholesterol in triglyceride-rich particles, which the LDL to HDL ratio leaves out.
Non-HDL cholesterol uses the same two inputs but subtracts instead of divides, giving an absolute amount of atherogenic cholesterol. Many current guidelines focus on LDL and non-HDL cholesterol, so the ratio is usually read alongside them, not instead of them.
The Heart health panel measures the values this calculator uses. Related: total cholesterol, hdl cholesterol, cholesterol hdl ratio.
A cholesterol HDL ratio calculator divides total cholesterol by HDL cholesterol, with both values in the same units, and returns one unitless number. Lower means a larger share of your cholesterol is carried in HDL particles. The calculator above does that arithmetic for you. It summarises a lipid panel, it does not diagnose anything.
The number is only as good as the two inputs behind it, and two very different lipid panels can produce an identical ratio. The sections below cover how the calculation works, how to read the result next to LDL cholesterol, non-HDL cholesterol and ApoB, and what tends to move it.
The calculator takes exactly two inputs from a standard lipid panel, total cholesterol and HDL cholesterol, and divides the first by the second. Nothing else enters the formula. Triglycerides, LDL cholesterol and ApoB sit on the same report but play no part in this particular number.
The only real rule is unit consistency. If total cholesterol is reported in mg/dL, HDL has to be in mg/dL too. If the lab reports in mmol/L, both go in as mmol/L. A total cholesterol of 220 mg/dL with an HDL of 55 mg/dL gives a ratio of 4.0. The same panel reported as 5.7 mmol/L and 1.4 mmol/L gives roughly 4.1, the small difference being rounding. Because the units cancel out, the result itself has no units, which is why a ratio calculated from a mg/dL report can be compared with one calculated from a mmol/L report. Mixing the two units in the same calculation produces a number that looks plausible and means nothing.
One quirk is worth knowing before you read the output. Total cholesterol already includes the cholesterol carried in HDL particles, so HDL sits on both sides of the division. Raising HDL lowers the ratio twice over, once by shrinking the numerator relative to the denominator and once by enlarging the denominator. That sensitivity is part of why the ratio moves more dramatically than either input on its own.
A lower ratio means proportionally more of your circulating cholesterol is travelling in HDL particles, and a higher ratio means proportionally more of it is in the particles usually counted as atherogenic. A ratio above about 5 is the point at which many reports flag the value for follow-up. That threshold is a convention used in reporting rather than a diagnostic cut-off, and it varies by laboratory, by sex and by the reference population the lab uses, so read your own report's stated range first.
The useful way to handle any result is observation, then meaning, then next step. The observation is the number itself. The meaning is probabilistic, a higher ratio may reflect a lipid pattern worth looking at more closely, often alongside body composition, blood pressure, glucose handling and family history. Research suggests that higher serum total cholesterol is associated with higher risk of cardiovascular death across prospective cohorts, though that is population-level evidence about group risk, not a prediction about any individual 1. The next step is a conversation, not a conclusion. A single ratio outside a reference band is a prompt to test again properly and discuss the full panel, never a diagnosis on its own.
A result in a favourable band is also not a clean bill of health. The ratio is a summary statistic, and summaries lose information by design.
Because a quotient can be reached from many directions. Consider a total cholesterol of 260 mg/dL with an HDL of 75 mg/dL. The ratio is about 3.5, which sits in a reassuring band, while the total cholesterol itself is well above the usual reference range. Now consider a total cholesterol of 160 mg/dL with an HDL of 32 mg/dL. The ratio is 5.0 and gets flagged, even though the total looks unremarkable. Same arithmetic, opposite stories.
The second trap is the assumption that a high HDL always improves the picture. HDL is a carrier, and the amount of cholesterol it carries is not the same thing as how well it functions. A very high HDL can pull a ratio into a favourable band without telling you anything about the number of atherogenic particles circulating alongside it.
The third trap is the one the formula cannot escape. Two people with identical ratios can have very different LDL cholesterol, triglycerides and particle counts. That is why the ratio works best as a quick orientation at the top of a panel, read alongside the individual values rather than instead of them.
Quite a lot, and most of it is fixable with a careful retest rather than a reinterpretation.
Measurement variation comes first. Lipid values fluctuate from day to day within the same person, and different laboratories use different assays and calibration, so a small shift between two reports may be analytical noise rather than a real change. Comparing results from the same lab, measured the same way, removes most of that confusion.
State at the time of the draw matters too. Acute illness or recent infection, a period of rapid weight loss or weight gain, heavy alcohol intake in the preceding days, major changes in training load, pregnancy, and significant stress can all shift lipids temporarily. Hydration and posture before the draw can nudge values slightly. Fasting status mostly affects triglycerides and the LDL cholesterol that is calculated from them, which means it can change the numbers you read next to the ratio even when total cholesterol and HDL move very little.
Then there is the calculator itself. Entering values from different reports, mixing mg/dL with mmol/L, or typing an LDL value where total cholesterol belongs all produce a number that looks like a result. The output is arithmetic performed on whatever you typed, not a measurement, and it cannot replace a blood test.
The ratio is a headline. The markers below are the article. Reading them together is what turns a number into something a clinician can work with, and the Cholesterol / HDL Ratio biomarker page covers the value itself in more depth.
| Marker | What it measures | What it adds next to the ratio |
|---|---|---|
| LDL cholesterol | Cholesterol carried in low-density lipoprotein particles | The single value most lipid reports are built around, often calculated rather than measured directly |
| Non-HDL cholesterol | Total cholesterol minus HDL cholesterol | Captures cholesterol in all atherogenic particles in one figure, and is not thrown off by fasting status the way calculated LDL can be |
| ApoB | The number of atherogenic particles, since each carries one ApoB molecule | Distinguishes many small particles from fewer large ones, a difference the cholesterol values cannot see |
| Triglycerides | Fat carried in the blood, largely in VLDL particles | Often moves with metabolic health, insulin sensitivity and recent diet |
| HDL cholesterol | Cholesterol carried in high-density lipoprotein particles | One of the two inputs, worth reading on its own rather than only as part of the quotient |
A practical way to sequence them is to glance at the ratio for orientation, read non-HDL cholesterol for the total atherogenic cholesterol load, then look at ApoB if it was measured, because particle count can disagree with cholesterol content. Where they disagree, the disagreement is the interesting finding, and it belongs in a clinical conversation.
Most standard lipid panels report total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides, and many calculate the total cholesterol to HDL ratio automatically. If yours does not, the calculator above fills the gap from the two values you already have.
FitScript measures the components of this ratio within its Heart Health panel, alongside the wider lipid and cardiometabolic markers drawn as part of 150+ biomarkers tested per year. Results are interpreted by Atlas, FitScript's AI health advisor, and any treatment decision is made by a licensed provider who evaluates whether it is appropriate after reviewing the member.
One retest habit is worth building. Lipids are tracked as a trend, so testing at a similar time of day, under similar conditions, through the same lab, makes the comparison between two reports mean something.
Because HDL sits in the denominator and inside the numerator, the ratio responds both to changes in atherogenic cholesterol and to changes in HDL. Several lifestyle factors have been studied against lipid outcomes.
Exercise is the most consistently studied lever. Research suggests that structured exercise training improves blood lipid profiles, including HDL cholesterol, across a broad range of trial populations 2.
Dietary pattern matters as much as any single food. In a randomised trial, a Mediterranean-style diet improved several cardiovascular risk factors compared with the control diet 3. Fat quality is one mechanism behind that, and a network meta-analysis found that replacing solid fats with certain vegetable oils is associated with more favourable blood lipid profiles 4. Looking at one oil specifically, studies suggest that canola oil intake may lower total and LDL cholesterol in controlled trials 5.
Soluble fibre is a second mechanism. In a randomised controlled trial, an oat beta-glucan beverage reduced LDL cholesterol in men and women with borderline high cholesterol 6.
Dietary cholesterol itself has been reconsidered, and a review of the evidence suggests that, for most people, cholesterol eaten in food has a smaller effect on blood cholesterol than was once assumed, with meaningful variation between individuals 7.
Energy intake and macronutrient mix both show up in the literature too. Exploratory outcomes from a two year randomised trial of calorie restriction in healthy non-obese adults suggest improvements across several cardiometabolic risk markers 8. A meta-analysis of randomised trials of carbohydrate-restricted diets found that effects on cardiovascular markers and body composition depend heavily on which macronutrient replaces the carbohydrate 9.
None of this is a programme, and none of it includes supplement amounts, because the right combination depends on the rest of your panel and your history.
Take it to a clinician when the ratio sits above your lab's flagged range on more than one test, when the ratio looks acceptable but total cholesterol, LDL cholesterol, non-HDL cholesterol or ApoB sits outside the reference range, when HDL is low enough to be doing most of the work in the quotient, or when triglycerides are elevated at the same time. A strong family history of early cardiovascular disease, a known metabolic condition, or a markedly suboptimal value on a first panel are all reasons to arrange a conversation promptly rather than waiting for the next scheduled draw.
Never treat a flagged result as something to ignore, and never treat a favourable ratio as a reason to skip follow-up on an individual value that is out of range. If a treatment is ever part of the answer, a licensed provider evaluates whether it is appropriate for you after reviewing your results, history and medications.
This page is educational and is not medical advice. Discuss your results and any treatment decisions with a clinician or licensed provider who can see your full history.
For related reading, see does coffee raise cholesterol for how an everyday habit can show up on a lipid panel, and how do cholesterol lowering medications work for a plain explanation of the options a licensed provider assesses for appropriateness before anything is prescribed.
In the review cited here, lower ratios went with lower cardiovascular risk, with prevention targets below 4.5 for men and 4.0 for women.
No, as long as both values are in the same unit. The units cancel out in the ratio.
The review found the total to HDL and LDL to HDL ratios had greater predictive value than single lipid values, particularly LDL. A clinician reads them together.
Total cholesterol divided by HDL cholesterol, with both values taken from the same lipid panel and entered in the same units. The result has no units, so a ratio worked out from a mg/dL report can be compared directly with one worked out from a mmol/L report.
Lower is generally read as more favourable. As a rough convention, a ratio above about 5 is commonly flagged for follow-up. This is a reporting convention that varies by lab and sex, not a diagnostic cut-off, so check the range printed on your own report.
Yes, as long as both inputs use the same unit. Mixing a total cholesterol in mg/dL with an HDL in mmol/L gives a number that looks reasonable and means nothing.
Fasting mainly affects triglycerides and the LDL cholesterol that is calculated from them, rather than total cholesterol and HDL. Follow whatever instruction the ordering clinician or the lab gives you, and keep the conditions consistent between tests so the trend stays comparable.
Not automatically. A low ratio can come from a high HDL that is masking a high total cholesterol, and the amount of cholesterol HDL carries is not the same as how well those particles function. Read the individual values alongside the ratio.
They answer different questions. The ratio is a quick orientation to the balance of your panel, while LDL cholesterol, non-HDL cholesterol and ApoB describe the atherogenic side of it directly. A clinician reading your panel will weigh them together with your history.
Day to day variation, a different laboratory or assay, recent illness, rapid weight change, alcohol intake, a big shift in training, or simply a different time of day can all move lipid values. Comparing results from the same lab, drawn under similar conditions, filters out most of that noise.
No. It performs arithmetic on two values you already have from a lipid panel. Without a measured total cholesterol and HDL, there is nothing for it to calculate.
That depends on your starting values, your history and what you are changing, which is a decision for the clinician ordering the test. Lipids are read as a trend, so a sensible rhythm matters more than any single result.